Age 0 3 0 3 B-age
≥ 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Any 0 3 15 18 O
number 4 10 19 25 O
of 11 13 26 28 O
metastatic 14 24 29 39 B-cancer
disease 25 32 40 47 I-cancer
is 33 35 48 50 O
allowed 36 43 51 58 O
in 44 46 59 61 O
the 47 50 62 65 O
Pilot 51 56 66 71 O
phase 57 62 72 77 O
of 63 65 78 80 O
the 66 69 81 84 O
trial 70 75 85 90 O

Any 0 3 91 94 O
serum 4 9 95 100 B-clinical_variable
AST 10 13 101 104 I-clinical_variable
is 14 16 105 107 O
allowed 17 24 108 115 O
but 25 28 116 119 O
serum 29 34 120 125 O
AST 35 38 126 129 O
≤ 39 40 130 131 O
34 41 43 132 134 B-upper_bound
IU 44 46 135 137 I-upper_bound
/ 46 47 137 138 I-upper_bound
L 47 48 138 139 I-upper_bound
is 49 51 140 142 O
strongly 52 60 143 151 O
encouraged 61 71 152 162 O

Any 0 3 163 166 O
serum 4 9 167 172 B-clinical_variable
Albumin 10 17 173 180 I-clinical_variable
is 18 20 181 183 O
allowed 21 28 184 191 O
, 28 29 191 192 O
but 30 33 193 196 O
≥ 34 35 197 198 O
3.4 36 39 199 202 B-lower_bound
g 40 41 203 204 I-lower_bound
/ 41 42 204 205 I-lower_bound
dL 42 44 205 207 I-lower_bound
is 45 47 208 210 O
strongly 48 56 211 219 O
encouraged 57 67 220 230 O

Patient 0 7 231 238 O
eligible 8 16 239 247 O
for 17 20 248 251 O
IVC 21 24 252 255 B-treatment
tumor 25 30 256 261 I-treatment
thrombectomy 31 43 262 274 I-treatment
as 44 46 275 277 O
decided 47 54 278 285 O
by 55 57 286 288 O
the 58 61 289 292 O
treating 62 70 293 301 O
urologist 71 80 302 311 O

Patient 0 7 312 319 O
eligible 8 16 320 328 O
for 17 20 329 332 O
SABR 21 25 333 337 B-treatment
to 26 28 338 340 O
the 29 32 341 344 O
IVC 33 36 345 348 B-cancer
tumor 37 42 349 354 I-cancer
thrombus 43 51 355 363 I-cancer
as 52 54 364 366 O
decided 55 62 367 374 O
by 63 65 375 377 O
the 66 69 378 381 O
treating 70 78 382 390 O
radiation 79 88 391 400 O
oncologist 89 99 401 411 O

Performance 0 11 412 423 B-clinical_variable
status 12 18 424 430 I-clinical_variable
ECOG 19 23 431 435 I-clinical_variable
0 24 25 436 437 B-lower_bound
- 25 26 437 438 O
2 26 27 438 439 B-upper_bound

Radiographic 0 12 440 452 B-treatment
evidence 13 21 453 461 O
of 22 24 462 464 O
renal 25 30 465 470 B-cancer
cancer 31 37 471 477 I-cancer
with 38 42 478 482 O
IVC 43 46 483 486 O
tumor 47 52 487 492 B-cancer
thrombus 53 61 493 501 I-cancer

Should 0 6 502 508 O
a 7 8 509 510 O
woman 9 14 511 516 B-gender
become 15 21 517 523 O
pregnant 22 30 524 532 B-pregnancy
or 31 33 533 535 O
suspect 34 41 536 543 O
she 42 45 544 547 O
is 46 48 548 550 O
pregnant 49 57 551 559 O
while 58 63 560 565 O
participating 64 77 566 579 O
in 78 80 580 582 O
this 81 85 583 587 O
study 86 91 588 593 O
, 91 92 593 594 O
she 93 96 595 598 O
should 97 103 599 605 O
inform 104 110 606 612 O
her 111 114 613 616 O
treating 115 123 617 625 O
physician 124 133 626 635 O
immediately 134 145 636 647 O

Subjects 0 8 648 656 O
may 9 12 657 660 O
have 13 17 661 665 O
received 18 26 666 674 O
any 27 30 675 678 O
other 31 36 679 684 O
investigational 37 52 685 700 O
agents 53 59 701 707 O
or 60 62 708 710 O
chemotherapy 63 75 711 723 B-treatment
as 76 78 724 726 O
long 79 83 727 731 O
as 84 86 732 734 O
they 87 91 735 739 O
are 92 95 740 743 O
eligible 96 104 744 752 O
for 105 108 753 756 O
SABR 109 113 757 761 B-treatment
and 114 117 762 765 I-treatment
surgery 118 125 766 773 I-treatment

Subjects 0 8 774 782 O
must 9 13 783 787 O
be 14 16 788 790 O
able 17 21 791 795 O
to 22 24 796 798 O
undergo 25 32 799 806 O
either 33 39 807 813 O
a 40 41 814 815 O
contrast 42 50 816 824 O
enhanced 51 59 825 833 O
MRI 60 63 834 837 B-treatment
or 64 66 838 840 O
CT 67 69 841 843 B-treatment

Subjects 0 8 844 852 O
must 9 13 853 857 B-pregnancy
not 14 17 858 861 I-pregnancy
be 18 20 862 864 I-pregnancy
pregnant 21 29 865 873 I-pregnancy
due 30 33 874 877 O
to 34 36 878 880 O
the 37 40 881 884 O
potential 41 50 885 894 O
for 51 54 895 898 O
congenital 55 65 899 909 O
abnormalities 66 79 910 923 O

Subjects 0 8 924 932 O
who 9 12 933 936 O
have 13 17 937 941 O
had 18 21 942 945 O
radiotherapy 22 34 946 958 B-treatment
to 35 37 959 961 O
a 38 39 962 963 O
target 40 46 964 970 O
within 47 53 971 977 O
3 54 55 978 979 B-upper_bound
cm 56 58 980 982 I-upper_bound
of 59 61 983 985 O
the 62 65 986 989 O
IVC 66 69 990 993 B-clinical_variable
tumor 70 75 994 999 I-clinical_variable
thrombus 76 84 1000 1008 I-clinical_variable

Subjects 0 8 1009 1017 O
with 9 13 1018 1022 O
a 14 15 1023 1024 O
history 16 23 1025 1032 O
of 24 26 1033 1035 O
pulmonary 27 36 1036 1045 B-chronic_disease
embolism 37 45 1046 1054 I-chronic_disease
is 46 48 1055 1057 O
excluded 49 57 1058 1066 O

Subjects 0 8 1067 1075 O
with 9 13 1076 1080 O
a 14 15 1081 1082 O
history 16 23 1083 1090 O
of 24 26 1091 1093 O
pulmonary 27 36 1094 1103 B-chronic_disease
hypertension 37 49 1104 1116 I-chronic_disease
is 50 52 1117 1119 O
excluded 53 61 1120 1128 O

Subjects 0 8 1129 1137 O
with 9 13 1138 1142 O
brain 14 19 1143 1148 B-cancer
metastases 20 30 1149 1159 I-cancer
should 31 37 1160 1166 O
be 38 40 1167 1169 O
excluded 41 49 1170 1178 O
from 50 54 1179 1183 O
this 55 59 1184 1188 O
clinical 60 68 1189 1197 O
trial 69 74 1198 1203 O
unless 75 81 1204 1210 O
all 82 85 1211 1214 O
the 86 89 1215 1218 O
metastasis 90 100 1219 1229 B-cancer
are 101 104 1230 1233 O
treated 105 112 1234 1241 O
surgically 113 123 1242 1252 O
or 124 126 1253 1255 O
radio 127 132 1256 1261 O
- 132 133 1261 1262 O
surgically 133 143 1262 1272 O

Surgery 0 7 1273 1280 B-treatment
or 8 10 1281 1283 O
SABR 11 15 1284 1288 B-treatment
of 16 18 1289 1291 O
metastatic 19 29 1292 1302 B-cancer
site 30 34 1303 1307 O
concurrently 35 47 1308 1320 O
or 48 50 1321 1323 O
at 51 53 1324 1326 O
any 54 57 1327 1330 O
time 58 62 1331 1335 O

Tumor 0 5 1336 1341 B-cancer
thrombus 6 14 1342 1350 I-cancer
must 15 19 1351 1355 O
be 20 22 1356 1358 O
≥ 23 24 1359 1360 O
level 25 30 1361 1366 B-lower_bound
II 31 33 1367 1369 I-lower_bound

Women 0 5 1370 1375 B-gender
of 6 8 1376 1378 O
child 9 14 1379 1384 O
- 14 15 1384 1385 O
bearing 15 22 1385 1392 O
potential 23 32 1393 1402 O
and 33 36 1403 1406 O
men 37 40 1407 1410 O
must 41 45 1411 1415 O
agree 46 51 1416 1421 B-contraception_consent
to 52 54 1422 1424 I-contraception_consent
use 55 58 1425 1428 I-contraception_consent
adequate 59 67 1429 1437 I-contraception_consent
contraception 68 81 1438 1451 I-contraception_consent
( 82 83 1452 1453 O
hormonal 83 91 1453 1461 B-contraception_consent
or 92 94 1462 1464 O
barrier 95 102 1465 1472 B-contraception_consent
method 103 109 1473 1479 I-contraception_consent
of 110 112 1480 1482 I-contraception_consent
birth 113 118 1483 1488 I-contraception_consent
control 119 126 1489 1496 I-contraception_consent
; 126 127 1496 1497 O
abstinence 128 138 1498 1508 B-contraception_consent
) 138 139 1508 1509 O
prior 140 145 1510 1515 O
to 146 148 1516 1518 O
study 149 154 1519 1524 O
entry 155 160 1525 1530 O
, 160 161 1530 1531 O
for 162 165 1532 1535 O
the 166 169 1536 1539 O
duration 170 178 1540 1548 O
of 179 181 1549 1551 O
study 182 187 1552 1557 O
participation 188 201 1558 1571 O
, 201 202 1571 1572 O
and 203 206 1573 1576 O
for 207 210 1577 1580 O
90 211 213 1581 1583 B-upper_bound
days 214 218 1584 1588 I-upper_bound
following 219 228 1589 1598 O
completion 229 239 1599 1609 O
of 240 242 1610 1612 O
therapy 243 250 1613 1620 B-treatment

cardiac 0 7 1621 1628 B-treatment
pacemaker 8 17 1629 1638 I-treatment

claustrophobia 0 14 1639 1653 B-chronic_disease

impairment 0 10 1654 1664 O
of 11 13 1665 1667 O
the 14 17 1668 1671 O
renal 18 23 1672 1677 O
function 24 32 1678 1686 O
with 33 37 1687 1691 O
estimated 38 47 1692 1701 B-clinical_variable
glomerular 48 58 1702 1712 I-clinical_variable
filtration 59 69 1713 1723 I-clinical_variable
rate 70 74 1724 1728 I-clinical_variable
( 75 76 1729 1730 I-clinical_variable
eGFR 76 80 1730 1734 I-clinical_variable
) 80 81 1734 1735 I-clinical_variable
< 82 83 1736 1737 O
30 84 86 1738 1740 B-upper_bound
mL 87 89 1741 1743 I-upper_bound
/ 89 90 1743 1744 I-upper_bound
min/1.73m2 90 100 1744 1754 I-upper_bound

pregnant 0 8 1755 1763 B-pregnancy
or 9 11 1764 1766 O
nursing 12 19 1767 1774 O

